Home
/
Perspective Therapeutics, Inc.
/
Financials
/
Quarterly
Perspective Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Perspective Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2023
$2.19M
Nov 14, 2023
Q2
2023
Jun 30, 2023
$2.09M
Aug 11, 2023
Q1
2023
Mar 31, 2023
$2.06M
May 15, 2023
Q3
2023
Sep 30, 2022
$1.72M
Nov 14, 2023
Q2
2023
Jun 30, 2022
$2.51M
Aug 11, 2023
Q1
2023
Mar 31, 2022
$2.91M
May 15, 2023
Q2
2019
Dec 31, 2018
$1.90M
Feb 13, 2019
Q1
2019
Sep 30, 2018
$1.56M
Nov 9, 2018
Q3
2018
Mar 31, 2018
$1.57M
May 4, 2018
Q2
2019
Dec 31, 2017
$1.54M
Feb 13, 2019
Q1
2019
Sep 30, 2017
$1.21M
Nov 9, 2018
Q3
2018
Mar 31, 2017
$1.28M
May 4, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($25.97M)
Nov 10, 2025
Q3
2025
Jun 30, 2025
($21.49M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($21.49M)
Aug 13, 2025
Q3
2025
Mar 31, 2025
($18.18M)
Nov 10, 2025
Q2
2025
Mar 31, 2025
($18.18M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($18.18M)
May 12, 2025
Q3
2025
Sep 30, 2024
($15.12M)
Nov 10, 2025
Q3
2025
Jun 30, 2024
($11.70M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($11.70M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($12.28M)
May 12, 2025
Q3
2025
Mar 31, 2024
($12.28M)
Nov 10, 2025
Q2
2025
Mar 31, 2024
($12.28M)
Aug 13, 2025
Q3
2024
Sep 30, 2023
($10.36M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($11.11M)
Aug 13, 2024
Q3
2024
Jun 30, 2023
($11.11M)
Nov 12, 2024
Q1
2024
Mar 31, 2023
($371.0K)
May 15, 2024
Q2
2024
Mar 31, 2023
($371.0K)
Aug 13, 2024
Q3
2024
Mar 31, 2023
($371.0K)
Nov 12, 2024
Q3
2023
Sep 30, 2022
($4.07M)
Nov 14, 2023
Q1
2023
Sep 30, 2022
($4.07M)
Nov 14, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($27.86M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($24.04M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($21.83M)
May 12, 2025
Q3
2025
Sep 30, 2024
($18.63M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($14.26M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($13.01M)
May 12, 2025
Q3
2024
Sep 30, 2023
($9.75M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($9.75M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($9.76M)
May 15, 2024
Q3
2023
Sep 30, 2022
($4.21M)
Nov 14, 2023
Q1
2023
Sep 30, 2022
($4.21M)
Nov 14, 2022
Q2
2023
Jun 30, 2022
($2.11M)
Aug 11, 2023
Q3
2022
Mar 31, 2022
($1.38M)
May 13, 2022
Q1
2023
Mar 31, 2022
($1.38M)
May 15, 2023
Q2
2022
Dec 31, 2021
($1.64M)
Feb 9, 2022
Q1
2023
Sep 30, 2021
($2.27M)
Nov 14, 2022
Q3
2022
Mar 31, 2021
($766.0K)
May 13, 2022
Q2
2022
Dec 31, 2020
($873.0K)
Feb 9, 2022
Q1
2022
Sep 30, 2020
($714.0K)
Nov 10, 2021
Q3
2021
Mar 31, 2020
($548.0K)
May 14, 2021